Acute panmyelosis with myelofibrosis

Source: Wikipedia, the free encyclopedia.
Acute panmyelosis with myelofibrosis
SpecialtyHematology, oncology

Acute panmyelosis with myelofibrosis (APMF) is a poorly defined disorder that arises as either a clonal disorder, or following toxic exposure to the bone marrow.[1]

Signs and symptoms

Bone biopsy shows abnormal megakaryocytes, macrocytic erythropoiesis, and defects in neutrophil production and fibrosis of the marrow (myelofibrosis).

Clinically, patients present with reduction in the count of all blood cells (pancytopenia), very few blasts in the peripheral blood, and no or little spleen enlargement (splenomegaly).

Cells are usually CD34 positive.[2]

Prognosis and treatment

Autologous stem cell transplantation has been used in treatment.[3]

Terminology

Controversy remains today whether this disorder is a subtype of

myelodysplastic syndromes; however, it is currently classified as a form of AML.[4][5]

See also

References

  1. ^ Hoffman R, Benz E, Shattil S, Furie B, Cohen H (2004). Hematology: Basic Principles and Practice (4th ed.). Churchill Livingstone.
  2. PMID 15578075
    .
  3. .
  4. .
  5. .

See also

External links